Detalhe da pesquisa
1.
Clinical and histopathological features of myeloid neoplasms with concurrent Janus kinase 2 (JAK2) V617F and KIT proto-oncogene, receptor tyrosine kinase (KIT) D816V mutations.
Br J Haematol
; 194(2): 344-354, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34060083